MERLION Trial

Physician initiated, prospective, non-randomized Multi-center trial, investigating the safety and Efficacy of the tReatment with Luminor DCB and angiolite DES of IVascular in TASC C and D tibial Occlusive disease iN patients with critical limb ischaemia at 12-month follow up.

Device: luminor 14m or angiolite BTK

Number of patients: 50

Type of lesions: long tibial occlusive lesions TASC C and D

Merlion 6-Month outcomes
Merlion 6-Month outcomes

luminor DCB is safe and efficacious, in treating highly complex infra-popliteal atherosclerotic lesions in challenging CLTI patients. luminor is associated with highly satisfactory acute technical success, 6-month target lesion patency and AFS.

Presented by Dr Tang (Singapore) at VIVA 2020.

All Clinical Trials
TINTIN Trial
ANGIOLITE BTK Trial
EFFPAC Trial
BIBLIOS Trial
LUMINOR Registry